---
input_text: "The use Prometheus FPSA system in the treatment of acute liver failure:
  preliminary results. UNLABELLED: The preliminary outcomes of patients with acute
  liver failure treated with the Prometheus Fractionated Plasma Separation and Absorption
  (FPSA) system are presented herein. PATIENTS AND METHODS: The procedures were performed
  in 13 patients (4, intoxication by Amanita phalloides; 4, unknown reason; 3, acetaminophen
  intoxication; 1, Wilson disease, and 1, liver insufficiency after hemihepatectomy
  owing to metastases of colon adenocarcinoma). The patients were qualified for the
  procedure according to the King's College Hospital criteria. The patients' general
  status was assessed on basic of GCS, UNOS, and the 4-grade encephalopathy classifications.
  The procedures were performed with the Prometheus 4008H Fresenius Medical Care unit.
  RESULTS: The 29 procedures were of mean duration 6.5 hours. There were statistically
  significant reductions in total bilirubin, ammonia, and aminotransferase levels.
  In addition, the procedures corrected water, mineral, and carbohydrate disorders.
  One patient did not require liver transplantation. Seven patients received liver
  transplants: three patients with positive outcomes; two died due to septicemia within
  30 days perioperatively, one died at 6 months after OLT owing to respiratory failure;
  and one, owing to hemorrhagic diathesis. Four patients did not receive a liver transplant
  because of lack of a organ, no consent for the surgery, or neoplastic disease with
  metastases. CONCLUSIONS: The Prometheus FPSA-System was an effective detoxication
  method for patients with acute liver failure. The system was useful as a symptomatic
  treatment before liver transplantation allowing a longer wait for a graft."
raw_completion_output: |-
  primary_disease: acute liver failure
  medical_actions: use of Prometheus FPSA system; liver transplantation
  symptoms: intoxication by Amanita phalloides; unknown reason; intoxication by acetaminophen; Wilson disease; liver insufficiency after hemihepatectomy; metastases of colon adenocarcinoma; high levels of total bilirubin; high ammonia levels; high aminotransferase levels; water, mineral, and carbohydrate disorders; septicemia; respiratory failure; hemorrhagic diathesis
  chemicals: Amanita phalloides; acetaminophen
  action_annotation_relationships: use of Prometheus FPSA system TREATS intoxication by Amanita phalloides IN acute liver failure; use of Prometheus FPSA system TREATS unknown reason IN acute liver failure; use of Prometheus FPSA system TREATS intoxication by acetaminophen IN acute liver failure; use of Prometheus FPSA system TREATS Wilson disease IN acute liver failure; use of Prometheus FPSA system TREATS liver insufficiency after hemihepatectomy IN acute liver failure; use of Prometheus FPSA system TREATS metastases of colon adenocarcinoma IN acute liver failure;element of use of Prometheus FPSA system TREATS high levels of total bilirubin IN acute liver failure; use of Prometheus FPSA system TREATS high ammonia levels IN acute liver failure; use of Prometheus FPSA system TREATS high aminotransferase levels IN acute liver failure; use of Prometheus FPSA system TREATS water, mineral, and carbohydrate disorders IN acute liver failure; liver transplantation PREVENTS septicemia IN acute liver failure; liver transplantation PREVENTS respiratory failure IN acute liver failure; liver transplantation PREVENTS hemorrhagic diathesis IN acute liver failure
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  liver transplantation PREVENTS hemorrhagic diathesis IN acute liver failure

  ===

extracted_object:
  primary_disease: MONDO:0019542
  medical_actions:
    - use of Prometheus FPSA system
    - MAXO:0001175
  symptoms:
    - intoxication by Amanita phalloides
    - unknown reason
    - intoxication by acetaminophen
    - Wilson disease
    - liver insufficiency after hemihepatectomy
    - metastases of colon adenocarcinoma
    - high levels of total bilirubin
    - high ammonia levels
    - high aminotransferase levels
    - water, mineral, and carbohydrate disorders
    - HP:0100806
    - HP:0002878
    - HP:0001892
  chemicals:
    - Amanita phalloides
    - CHEBI:46195
  action_annotation_relationships:
    - subject: use of Prometheus FPSA system
      predicate: TREATS
      object: intoxication by Amanita phalloides
      qualifier: MONDO:0019542
      subject_extension: Prometheus FPSA system
    - subject: use of Prometheus FPSA system
      predicate: TREATS
      object: unknown reason
      qualifier: MONDO:0019542
      subject_extension: Prometheus FPSA system
      object_extension: unknown reason
    - subject: use
      predicate: TREATS
      object: intoxication
      qualifier: MONDO:0019542
      object_qualifier: by acetaminophen
      subject_extension: Prometheus FPSA system
      object_extension: acetaminophen
    - subject: use of Prometheus FPSA system
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
      subject_extension: Prometheus FPSA system
    - subject: use of Prometheus FPSA system
      predicate: TREATS
      object: HP:0001399
      qualifier: MONDO:0019542
      subject_qualifier: after hemihepatectomy
      subject_extension: Prometheus FPSA system
    - subject: use of Prometheus FPSA system
      predicate: TREATS
      object: metastases of colon adenocarcinoma
      qualifier: MONDO:0019542
      subject_extension: Prometheus FPSA system
    - subject: use of Prometheus FPSA system
      predicate: TREATS
      object: high levels of total bilirubin
      qualifier: MONDO:0019542
      subject_extension: Prometheus FPSA system
    - subject: use of Prometheus FPSA system
      predicate: TREATS
      object: high ammonia levels
      qualifier: MONDO:0019542
      subject_extension: Prometheus FPSA system
    - subject: use of Prometheus FPSA system
      predicate: TREATS
      object: high aminotransferase levels
      qualifier: MONDO:0019542
      subject_extension: Prometheus FPSA system
    - subject: use of Prometheus FPSR system
      predicate: TREATS
      object: water, mineral, and carbohydrate disorders
      qualifier: MONDO:0019542
      subject_extension: Prometheus FPSA system
    - subject: MAXO:0001175
      predicate: PREVENTS
      object: HP:0100806
      qualifier: MONDO:0019542
    - subject: MAXO:0001175
      predicate: PREVENTS
      object: HP:0002878
      qualifier: MONDO:0019542
    - subject: MAXO:0001175
      predicate: PREVENTS
      object: HP:0001892
      qualifier: MONDO:0019542
named_entities:
  - id: MONDO:0010200
    label: Wilson disease
  - id: MAXO:0001175
    label: liver transplantation
  - id: MAXO:0000004
    label: surgery (laparotomy, rectal mobilization, rectopexy, the partial sigmoid
      colon resection with the primary anastomosis)
  - id: HP:0002910
    label: abnormal liver functions
  - id: HP:0001394
    label: cirrhosis
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:50868
    label: penicillamine
  - id: CHEBI:51232
    label: Hoechst 33342
  - id: HP:0006554
    label: acute liver failure
  - id: MAXO:0000068
    label: transplantation
  - id: MAXO:0009095
    label: Zinc therapy
  - id: HP:0002344
    label: Neurologic deterioration
  - id: MAXO:0001298
    label: therapy
  - id: HP:0001392
    label: liver disease
  - id: HP:0006579
    label: neonatal jaundice
  - id: HP:0002612
    label: congenital hepatic fibrosis
  - id: HP:0001409
    label: portal hypertension
  - id: HP:0030151
    label: cholangitis
  - id: MONDO:0013282
    label: alpha-1-antitrypsin deficiency
  - id: MONDO:0009061
    label: cystic fibrosis
  - id: MONDO:0009044
    label: Crigler-Najjar syndrome
  - id: MAXO:0000376
    label: liver biopsy
  - id: MAXO:0000127
    label: genetic testing
  - id: HP:0001903
    label: anemia
  - id: HP:0001410
    label: liver dysfunction
  - id: CHEBI:39501
    label: trientine
  - id: CHEBI:28694
    label: copper
  - id: HP:0001399
    label: hepatic failure
  - id: HP:0004448
    label: fulminant hepatic failure
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:33281
    label: Antibiotics
  - id: MONDO:0100193
    label: end-stage liver disease
  - id: HP:0100626
    label: end-stage liver disease
  - id: HP:0100660
    label: dyskinesia
  - id: HP:0004787
    label: fulminant hepatitis
  - id: HP:0031811
    label: bilirubinuria
  - id: HP:0001397
    label: hepatic steatosis
  - id: CHEBI:16359
    label: cholic acid
  - id: MONDO:0019542
    label: Acute liver failure (ALF)
  - id: HP:0002480
    label: Hepatic encephalopathy
  - id: CHEBI:27385
    label: CCL4
  - id: MAXO:0001017
    label: Vaccination
  - id: HP:0001541
    label: Ascites
  - id: HP:0012398
    label: Peripheral edema
  - id: HP:0001337
    label: tremor
  - id: HP:0001260
    label: dysarthria
  - id: HP:0000708
    label: psychiatric disorders
  - id: HP:0200123
    label: chronic hepatitis
  - id: CHEBI:38161
    label: chelators
  - id: MAXO:0000603
    label: peritoneal dialysis
  - id: CHEBI:7959
    label: D-penicillamine
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: HP:0002172
    label: imbalance
  - id: HP:0000093
    label: proteinuria
  - id: HP:0032199
    label: abnormal prothrombin time
  - id: MAXO:0000167
    label: Antiepileptic therapy
  - id: CHEBI:61049
    label: Tacrolimus
  - id: CHEBI:9168
    label: Rapamycin
  - id: CHEBI:55379
    label: Cyclosporine (CsA)
  - id: CHEBI:35623
    label: antiepileptic
  - id: CHEBI:4031
    label: Cyclosporine
  - id: HP:0000083
    label: renal failure
  - id: CHEBI:26708
    label: NA
  - id: CHEBI:35176
    label: zinc sulphate
  - id: HP:0001251
    label: ataxia
  - id: CHEBI:166831
    label: copper chelators
  - id: HP:0006577
    label: macronodular cirrhosis
  - id: CHEBI:8830
    label: rhodanine
  - id: CHEBI:18248
    label: iron
  - id: HP:0002015
    label: dysphagia
  - id: MONDO:0021200
    label: Rare diseases
  - id: MAXO:0000011
    label: Physiotherapy
  - id: MONDO:0001516
    label: spinal muscular atrophy
  - id: HP:0100806
    label: Sepsis
  - id: CHEBI:2948
    label: Azathioprine
  - id: CHEBI:8378
    label: Prednisolone
  - id: HP:0031690
    label: opportunistic infections
  - id: HP:0001513
    label: Obesity
  - id: HP:0000819
    label: Diabetes
  - id: HP:0002829
    label: Arthralgia
  - id: HP:0003281
    label: Elevated serum ferritin
  - id: HP:0012463
    label: Elevated transferrin saturation
  - id: CHEBI:9907
    label: Ursodeoxycholic acid
  - id: MONDO:0007027
    label: Non-alcoholic steatohepatitis (NASH)
  - id: MONDO:0006507
    label: Hereditary hemochromatosis (HH)
  - id: HP:0003256
    label: Coagulopathy
  - id: HP:0001298
    label: Encephalopathy
  - id: HP:0000952
    label: Jaundice
  - id: HP:0001289
    label: Confusion
  - id: MONDO:0003441
    label: dystonia
  - id: MAXO:0009015
    label: botulinum toxin injection
  - id: MAXO:0000943
    label: deep brain stimulation
  - id: CHEBI:9720
    label: trihexyphenidyl
  - id: HP:0001332
    label: dystonia
  - id: HP:0004305
    label: involuntary movements
  - id: CHEBI:46195
    label: acetaminophen
  - id: HP:0100520
    label: oliguria
  - id: CHEBI:16737
    label: creatinine
  - id: HP:0003259
    label: elevated creatinine
  - id: HP:0100543
    label: Cognitive impairment
  - id: CHEBI:33234
    label: vitamin E
  - id: MAXO:0000070
    label: Hepatic transplantation
  - id: HP:0001942
    label: metabolic acidosis
  - id: HP:0001953
    label: diabetic ketoacidosis (DKA)
  - id: CHEBI:145810
    label: insulin
  - id: HP:0003781
    label: Hypersalivation
  - id: HP:0002315
    label: Headache
  - id: HP:0002027
    label: Abdominal pain
  - id: HP:0002240
    label: Hepatomegaly
  - id: HP:0001744
    label: Splenomegaly
  - id: HP:0001873
    label: Thrombocytopenia
  - id: HP:0001250
    label: Convulsions
  - id: HP:0100785
    label: Insomnia
  - id: HP:0003394
    label: Muscle cramps
  - id: HP:0003401
    label: Paresthesia
  - id: HP:0025406
    label: Weakness
  - id: CHEBI:8764
    label: Mycophenolate mofetil
  - id: MONDO:0019737
    label: Thrombotic microangiopathy (TMA)
  - id: CHEBI:37153
    label: calcineurin inhibitors
  - id: MAXO:0001001
    label: gene therapy
  - id: CHEBI:30703
    label: tetrathiomolybdate
  - id: HP:0002878
    label: respiratory failure
  - id: HP:0001892
    label: hemorrhagic diathesis
